CEP
TECH icon

Chicago Equity Partners’s Bio-Techne TECH Stock Holding History

Chicago Equity Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-29,700
Closed -$1.55M – 956
2019
Q2 		$1.55M Buy
+29,700
New +$1.5M 0.07% 404
2018
Q2 		– Sell
-9,120
Closed -$344K – 900
2018
Q1 		$344K Buy
+9,120
New +$322K 0.01% 665

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Chicago Equity Partners's TECH Position: Q3 2019 in Review

Chicago Equity Partners sold out of Bio-Techne (TECH) in Q3 2019, closing a stake of 29,700 shares — an estimated $1.55M sold.

Chicago Equity Partners first reported a position in TECH in Q1 2018 and held it in 2 quarters. The position peaked at $1.55M in Q2 2019. 341 funds tracked by Wall St. Rank hold TECH as of Q3 2019.

  • Chicago Equity Partners reported no remaining Bio-Techne position as of Q3 2019 after selling out during the quarter.
  • Chicago Equity Partners sold 29,700 Bio-Techne shares in Q3 2019, an estimated $1.55M.
  • Chicago Equity Partners first reported a position in Bio-Techne in Q1 2018 and held it in 2 quarters.
  • Chicago Equity Partners's Bio-Techne position peaked at $1.55M in Q2 2019.
  • 341 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2019.

Based on Chicago Equity Partners's 13F filing for Q3 2019, filed 30 Oct 2019.